Is Cagrilintide legal?
Cagrilintide is not FDA approved as a finished drug. For drug-tested athletes it is not on the WADA prohibited list. Not yet approved. Trial access only.. Legal status depends on your country and changes over time. This reflects US status at the time of writing and is not legal or medical advice.
Regulatory status
- FDA: Investigational. Phase 3 trials by Novo Nordisk, often paired with semaglutide as 'CagriSema'.
- WADA: Not listed
- Prescription: Not yet approved. Trial access only.
References
- Once-weekly cagrilintide for weight management, Phase 2 trial — Lau DCW et al., Lancet, 2021
- Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity (REDEFINE 1) — Garvey et al., N Engl J Med, 2025
- Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2.4 mg for weight management: a randomised, controlled, phase 1b trial — Enebo et al., Lancet, 2021
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on Cagrilintide
Last updated 2026-06-06.